METOCLOPRAMIDE IN DIAGNOSIS OF PHEOCHROMOCYTOMA 559 Table I . Profiles of the Patients with Pheochromocytoma

Cardiovascular and plasma catecholamine responses to metoclopramide (MCP), a dopamine antagonist, were examined in 5 patients with pheochromocytoma, 12 patients with essential hypertension (EHT) and 9 normotensive (NT) subjects who displayed symptoms suggestive of pheochromocytoma on a constant daily intake of 100mEq sodium and 80mEq potassium. Significant pressor responses to intravenous doses of 5mg of MCP, which produced no serious pressor episodes and no other undesirable side effects, were found only in the patients with pheochromocytoma, in contrast to the subjects with EHT and NT who tended to display slight depressor responses. After curative surgery for pheochromocytoma, the MCP-induced pressor effects returned to normal. Furthermore, the enhanced pressor effects of MCP in the patients with pheochromocytoma were associated with increased plasma norepinephrine (NE) concentrations. However, the plasma epinephrine (E) concentrations remained unchanged after the MCP injection. Thus, this dose of MCP appears to be a more suitable vasopressor provocative agent in the pharmacological diagnosis of pheochromocytoma compared to currently used agents.

[1]  S. Sheps,et al.  Current Experience in the Diagnosis of Pheochromocytoma , 1966, Circulation.

[2]  L. Iseri,et al.  Use of adrenolytic drug, regitine, in pheochromocytoma , 1951 .

[3]  G. Haeusler.  Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  R W Gifford,et al.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. , 1981, The New England journal of medicine.

[5]  E. Orgain,et al.  Use of piperoxan and regitine as routine tests in patients with hypertension. , 1951, Journal of the American Medical Association.

[6]  C. Mathias,et al.  The central hypotensive effect of clonidine; Studies in tetraplegie subjcets , 1977, Clinical pharmacology and therapeutics.

[7]  A. Sjoerdsma,et al.  A NEW TEST FOR PHEOCHROMOCYTOMA. PRESSOR RESPONSIVENESS TO TYRAMINE. , 1964, JAMA.

[8]  G. M. Roth,et al.  A TENTATIVE TEST FOR PHEOCHROMOCYTOMA , 1945 .

[9]  J. Ménard,et al.  HYPERTENSIVE CRISIS IN PATIENT WITH PHÆOCHROMOCYTOMA GIVEN METOCLOPRAMIDE , 1976, The Lancet.

[10]  E. Adler-Graschinsky,et al.  Metoclopramide increases the release of catecholamines from isolated human phaeochromocytomas. , 1984, Journal of hypertension.

[11]  A. Lawrence.  Glucagon provocative test for pheochromocytoma. , 1967, Annals of internal medicine.

[12]  T. Waldmann,et al.  Pheochromocytoma: current concepts of diagnosis and treatment. Combined clinical staff conference at the National Institutes of Health. , 1966, Annals of internal medicine.

[13]  H. Spear,et al.  The use of dibenamine in pheochromocytoma; report of a case. , 1948, The New England journal of medicine.

[14]  C. Marsden,et al.  Metoclopramide and dopamine receptor blockade , 1976, Neuropharmacology.

[15]  J. Evans,et al.  Pheochromocytoma; report of a case, with a new diagnostic test. , 1948, The American journal of medicine.

[16]  G. Pack,et al.  The use of tetraethylammonium bromide as a diagnostic test for pheochromocytoma. , 1948, Proceedings. American Federation for Clinical Research.

[17]  R W Gifford,et al.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. , 1979, The New England journal of medicine.

[18]  T. Saruta,et al.  Endocrine factors in juvenile essential hypertension. , 1982, Japanese journal of medicine.